Inventor · disambiguated record
Boyu Zhong
Also filed as: ZHONG BOYU
17 granted patents·5 pending applications·50 citations·filing 2005–2024
91Inventor score
Files withIMMUNESENSOR THERAPEUTICS INC7LILLY CO ELI5GENEQUANTUM HEALTHCARE SUZHOU CO LTD3CROWN BIOSCIENCE INC TAIWAN2TYLIGAND BIOSCIENCE SHANGHAI LTD2
Top patents by PatentIndex Score
22 records- 0191US11999748B2Exatecan derivatives, linker-payloads, and conjugates and thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Granted Jun 4, 2024·1 cites·17 claims
- 0290US11814394B2Exatecan derivatives, linker-payloads, and conjugates and thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Granted Nov 14, 2023·1 cites·7 claims
- 0390US10947206B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Mar 16, 2021·3 cites·46 claims
- 0487US11597707B2CGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Mar 7, 2023·1 cites·26 claims
- 0587US8030302B2Amidophenoxyindazoles useful as inhibitors of c-MetLILLY CO ELI·Filed 2009·Granted Oct 4, 2011·12 cites·13 claims
- 0686US10519188B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·6 cites·21 claims
- 0785US7582638B2Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitorsLILLY CO ELI·Filed 2006·Granted Sep 1, 2009·11 cites·7 claims
- 0884US2025115564A1cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0983US7666879B2Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitorsLILLY CO ELI·Filed 2006·Granted Feb 23, 2010·10 cites·7 claims
- 1080US12065416B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·0 cites·32 claims
- 1174US9359338B2Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agentsCROWN BIOSCIENCE INC TAIWAN·Filed 2013·Granted Jun 7, 2016·2 cites·32 claims
- 1272US2025064957A1Exatecan derivatives, linker-payloads, and conjugates and thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 1370US2022340613A1Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1469US9695175B2Highly selective c-Met inhibitors as anticancer agentsCROWN BIOSCIENCE INC (TAIWAN)·Filed 2013·Granted Jul 4, 2017·1 cites·35 claims
- 1567USRE43878EAmidophenoxyindazoles useful as inhibitors of c-MetLI TIECHAO·Filed 2011·Granted Dec 25, 2012·2 cites·15 claims
- 1659US11299512B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2019·Granted Apr 12, 2022·0 cites·34 claims
- 1754US2024368211A1Processes of making onapristone and intermediates thereofCONTEXT BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1846US2023406849A1Kras inhibitors for treatment of cancersTYLIGAND BIOSCIENCE SHANGHAI LTD·Filed 2021·Application pending·0 cites
- 1943US7652015B2Kinase inhibitorsLILLY CO ELI·Filed 2006·Granted Jan 26, 2010·0 cites·9 claims
- 2040US11952364B2TRK inhibitors useful as anticancer drugsTYLIGAND BIOSCIENCE SHANGHAI LTD·Filed 2019·Granted Apr 9, 2024·0 cites·24 claims
- 2139US7767674B2Kinase inhibitorsLILLY CO ELI·Filed 2005·Granted Aug 3, 2010·0 cites·3 claims
- 2226US10023593B2ALK kinase inhibitor, and preparation method and uses thereofBEIJING PEARL BIOTECHNOLOGY LLC·Filed 2015·Granted Jul 17, 2018·0 cites·37 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →